BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 21631264)

  • 1. Molecular signatures of pancreatic cancer.
    Hong SM; Park JY; Hruban RH; Goggins M
    Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
    Pittman ME; Rao R; Hruban RH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ; Salisbury EL; Biankin AV; Kench J
    Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.
    Lüttges J; Klöppel G
    Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).
    Koorstra JB; Feldmann G; Habbe N; Maitra A
    Langenbecks Arch Surg; 2008 Jul; 393(4):561-70. PubMed ID: 18283486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.
    Paini M; Crippa S; Partelli S; Scopelliti F; Tamburrino D; Baldoni A; Falconi M
    World J Gastroenterol; 2014 Aug; 20(29):10008-23. PubMed ID: 25110429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precursor lesions of pancreatobiliary cancer].
    Sipos B; Henopp T
    Pathologe; 2011 Nov; 32 Suppl 2():224-31. PubMed ID: 21909795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
    Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
    Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic aspects of intraductal papillary-mucinous neoplasm and pancreatic intraepithelial neoplasia--their associations with carcinogenesis.
    Furukawa T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1329-37. PubMed ID: 17827903
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular pathways in pancreatic carcinogenesis.
    Macgregor-Das AM; Iacobuzio-Donahue CA
    J Surg Oncol; 2013 Jan; 107(1):8-14. PubMed ID: 22806689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.
    Ren B; Liu X; Suriawinata AA
    Am J Pathol; 2019 Jan; 189(1):9-21. PubMed ID: 30558727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.